The variant in TEX38 whose allele mismatches contribute to TRM in recipients
Variant . | Chromosome . | Position . | Alleles (ref/alt) . | rsID . | AA change* . | Impact† . | Minor allele . | MAF‡ . | Allele mismatch frequency§ . | Population MAF‖ . |
---|---|---|---|---|---|---|---|---|---|---|
exm56988 | 1 | 47139039 | C/T | rs200092801 | P178S | Tolerated | T | 3.05E−03 | 5.17E−03 | 1.60E−03 |
Variant . | Chromosome . | Position . | Alleles (ref/alt) . | rsID . | AA change* . | Impact† . | Minor allele . | MAF‡ . | Allele mismatch frequency§ . | Population MAF‖ . |
---|---|---|---|---|---|---|---|---|---|---|
exm56988 | 1 | 47139039 | C/T | rs200092801 | P178S | Tolerated | T | 3.05E−03 | 5.17E−03 | 1.60E−03 |
MAF, minor allele frequency.
The amino acid changes are based on transcript NM_001145474.
Prediction of functional impact of the AA change by SIFT56 or PolyPhen2.57
The MAF in recipients of cohort 1. The minor allele was not observed in recipients or donors of cohort 2.
The frequency of allele mismatch in recipient-donor pairs in cohort 1. This was calculated as the sum of absolute difference in allele dosage between all recipient-donor pairs divided by 2 times the number of recipient-donor pairs.
The MAF in the Exome Aggregation Consortium58 non-Finnish European population.